SCHEMBL20628720

SCHEMBL20628720

CCOC(=O)/C(F)=C/CC(NSC(C)(C)C)c1ccccc1F

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.34
SMN1; SMN2 Q16637 3/20 0.34
CYP1A2 P05177 2/20 0.34
CYP2C19 P33261 2/20 0.34
NPC1 O15118 2/20 0.34
RAB9A P51151 2/20 0.34
MAPT P10636 4/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
LMNA P02545 2/20 0.33
CYP2C9 P11712 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
CASP1 P29466 1/20 0.33
KDM4E B2RXH2 3/20 0.32
EEF2K O00418 1/20 0.32
TSHR P16473 1/20 0.32
GAA P10253 3/20 0.32
TDP1 Q9NUW8 2/20 0.32
TP53 P04637 1/20 0.32
ADRB2 P07550 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18522686 0.80 MAPT (0.41) ALDH1A1SMN1; SMN2CYP1A2CYP2C19NPC1
SCHEMBL20628725 0.77 OPRM1 (0.35) ALDH1A1SMN1; SMN2CYP1A2CYP2C19NPC1
SCHEMBL21677202 0.71 EEF2K (0.33) EEF2K
SCHEMBL5530167 0.66 MMP8 (0.49) ALDH1A1SMN1; SMN2CYP1A2CYP2C19NPC1
SCHEMBL31198091 0.66 PIN1 (0.41) ALDH1A1SMN1; SMN2CYP1A2CYP2C19NPC1
SCHEMBL10650360 0.64 PIN1 (0.42) ALDH1A1SMN1; SMN2CYP1A2CYP2C19NPC1
SCHEMBL12826218 0.64 MEN1 (0.37) ALDH1A1SMN1; SMN2CYP1A2CYP2C19MAPT
SCHEMBL26951141 0.64 CES2 (0.33)
SCHEMBL24555599 0.63 GPR35 (0.33) ALDH1A1MAPTNPSR1GAA
SCHEMBL18683323 0.63 TSHR (0.46) ALDH1A1CYP1A2CYP2C19RAB9AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3218362-B1 2-AMINO-3,5-DIFLUORO-3,6-DIMETHYL-6-PHENYL-3,4,5,6-TETRAHYDROPYRIDINES AS BACE1 INHIBITORS FOR TREATING ALZHEIMER'S DISEASE H LUNDBECK AS (DK) 2019-01-09 EP disclosed